Mortality PredictionNCT07769151
BIO-FUNCTION for Prediction Non Relapse Mortality in Transplant and Cell Therapy
An observational study of Mortality Prediction, run by Henry Ford Health System at 1 site in United States.
Trial summary
The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Mortality Prediction
- What is being tested?
- blood sample to check CXCL9 pre stem cell transplant and cell therapy
- How many people
- 124 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Oct 2026to 30 Dec 2031
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patients >18 year old planned for SCTCT
Who may be able to join
- patients >18 year old
- patients planned for SCTCT
Who cannot join
- Pregnancy
- prisoners
- Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Henry Ford Health
Detroit, Michigan, 48202
Shatha Farhan, 3137133910, sfarhan1@hfhs.org
About this study
Official title: BIO-FUNCTION for NRM Prediction in SCTCT: Assessing Biological and Functional Reserve to Predict Non-Relapse Mortality in Stem Cell Transplant and Cell Therapy
The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM.
- Conditions
- Mortality Prediction
- Being tested
- blood sample to check CXCL9 pre stem cell transplant and cell therapy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
blood sample to check CXCL9 pre stem cell transplant and cell therapyDiagnostic test
Pre SCTCT as per SOC physical function assessment will be performed in a form of IADl, hand grip, and or walk test like TUG. Specimen Collection Studies: LDH , albumin, ferritin, CRP, platelet and creatinine will be collected as per standard of care pre SCTCT. The non-SOC procedure will be drawing CXL9
What is being measured
The primary outcome is the main question the study is designed to answer.
Non relapse mortality (NRM)
Measured: NRM at day 100 and at year 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Aug 2026
- Study start1 Oct 2026
- Primary completion30 Dec 2030 (estimated)
- Study completion30 Dec 2031 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mortality PredictionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 124 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Henry Ford Health System
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Shatha Farhan, Henry Ford Health System
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07769151
- Sponsor's protocol ID
- 19170
- Status last verified
- Oct 2026
- First submitted
- 12 Aug 2026
- Last updated
- 19 Oct 2026
- Results posted
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 19 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- BIO-FUNCTION for NRM Prediction in SCTCT: Assessing Biological and Functional Reserve to Predict Non-Relapse Mortality in Stem Cell Transplant and Cell Therapy
- ClinicalTrials.gov ID
- NCT07769151
- Acronym / sponsor ID
- 19170
- Conditions
- Mortality Prediction
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 124 participants (estimated)
- Lead sponsor
- Henry Ford Health SystemUniversity, hospital or other
- Study start
- 1 Oct 2026 (actual)
- Primary completion
- 30 Dec 2030 (estimated)
- Study completion
- 30 Dec 2031 (estimated)
- First posted
- 17 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patients >18 year old planned for SCTCT
Key inclusion criteria (2 listed)
- patients >18 year old
- patients planned for SCTCT
Key exclusion criteria (3 listed)
- Pregnancy
- prisoners
- Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| blood sample to check CXCL9 pre stem cell transplant and cell therapyPre SCTCT as per SOC physical function assessment will be performed in a form of IADl, hand grip, and or walk test like TUG. Specimen Collection Studies: LDH , albumin, ferritin, CRP, platelet and creatinine will be collected as per standard of care pre SCTCT. The non-SOC procedure will be drawing CXL9 | Diagnostic test | – |
Primary outcome
Non relapse mortality (NRM)
Time frame: NRM at day 100 and at year 1
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Oct 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Mortality Prediction
RecruitingObservational study
Predictors of In-Hospital Mortality in Severe Abdominal Trauma
Abdominal Injuries, Wounds and Injuries
RecruitingObservational study
Tetanus Severity Score for Prediction of Mortality in Manifest Tetanus
Tetanus, Manifest
Not yet recruiting
Prediction and Prevention of Postoperative Mortality and Morbidity
Dementia, Postoperative Delirium (POD)
RecruitingObservational study
Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction
Septic Shock, VExUS
RecruitingObservational study
Mortality Prediction Using Trauma Scores
Trauma, Multiple
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Mortality Prediction, run by Henry Ford Health System at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 19 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Shatha Farhan, MD (3137133910, sfarhan1@hfhs.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Non relapse mortality (NRM) (time frame: NRM at day 100 and at year 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2026.